Pesticides and Child Health: Exposure Recognition and Prevention
To access this course, select Subscribe on the left. You will then be required to log-in or register if you do not already have an account.
The course will focus on the impact of pesticide exposures on human health at vulnerable stages of in utero and pediatric development, with consideration of risk reduction.
- Implement strategies that aid in overcoming diagnostic challenges associated with both acute and chronic pesticide exposures.
- Describe the signs and symptoms of acute organophosphate, carbamate, and pyrethroid poisoning in children given a set of pediatric case facts.
- Discuss the pediatric morbidities associated with early life pesticide exposure based on current toxicological and epidemiological data.
- Identify the appropriate anticipatory guidance that enables patients to limit childhood pesticide exposures given relevant case information
Catherine Karr, MD, PhD, MS
University of Washington, Seattle
PEHSU Region 10
Dr. Catherine Karr is a board-certified pediatrician with specialty training in environmental medicine. She received her M.D., M.S. in Toxicology/Environmental Health, and Ph.D. in Epidemiology at the University of Washington. She practices primary care general pediatrics and specialty environmental medicine consultation at UW Physicians Pediatric Care Center – Roosevelt in Seattle. She is also Co-Director of Northwest PEHSU (Region 10).
Margaret Willis, MPH, BSN
University of Washington Medical Center, Seattle
Margaret Willis received her MPH in Environmental and Occupational Health from the University of Washington, with a a special focus on pediatric environmental health issues. In addition to working as a clinical nurse in acute and community care settings for over a decade, she has worked as an educational assistant for the Northwest PEHSU, and completed a fellowship on policy issues in reproductive health from the University of California, San Francisco.
Approximate Completion Time
Continuing Education Information
This course qualifies as continuing education for physicians, nurses, certified health education specialists and other professionals provided by the Centers for Disease Control and its partners.
Origination Date – 03/01/16
Renewal Date - 03/01/18
Expiration Date – 03/01/20
.75 CME (for physicians)
.75 CME (attendance for non-physicians)
.6 CNE (for nurses)
.1 CEU (for other professionals)
CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and American College of Medical Toxicology. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Centers for Disease Control and Prevention designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 0.6 contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Charles A. McKay and h/she wishes to disclose _that he is a member of the Scientific Advisory Council, Environmental Health Research Foundation (EHRF). EHRF addresses issues related to biomonitoring, a topic that is also relevant to some of the activities. EHRF receives funding from sources that includes industry. Dr. McKay has reviewed and written material for the EHRF that could create a perceived conflict of interest regarding environmental chemical exposure assessment/measurement___.
Planning committee discussed conflict of interest with Dr. Charles A. McKay to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
The Centers for Disease Control and Prevention and American College of Medical Toxicology are jointly providing the CNE for this activity.
CDC did not accept commercial support for this activity.
Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications.
- Acute Exposures and Recognition
- Chronic Exposures and Prevention
- How To Obtain Continuing Education Credit